5 record-breaking biotech deals

The one bright spot in M&A in 2008 are drugmakers, where giant pharmaceutical companies are paying record amounts for biotechs to replenish their pipelines.

McCain's plan is the only one that has a chance of getting medical costs under control. An argument for some free-market sanity. (more)

The next President will have a fighting chance to defeat the lobbyists and reform a broken system. (more)

More Galleries

Stock repurchases are booming. These five companies are ready to spend over $79 billion on buybacks. More

McDonald's Happy is part of a long lineage of creatures great and small that shill for products and mortify consumers. Mr. Mucus, anyone? More

The top spots in the U.S. for new grads to land a job -- and actually enjoy life -- according to financial site WalletHub. More